387133006: Carisoprodol (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Centrally acting muscle relaxant (substance)\Carisoprodol (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Carbamate (substance)\Carisoprodol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carisoprodol (substance)	Is a	Centrally acting muscle relaxant (substance)	true	Inferred relationship	Some
Carisoprodol (substance)	Is a	Carbamate (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Carisoprodol measurement	Component	True	Carisoprodol (substance)	Inferred relationship	Some	1
Product containing carisoprodol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol adverse reaction	Causative agent (attribute)	True	Carisoprodol (substance)	Inferred relationship	Some	1
Allergy to carisoprodol	Causative agent (attribute)	False	Carisoprodol (substance)	Inferred relationship	Some
Carisoprodol 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some
Carisoprodol 350 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some
Product containing aspirin and carisoprodol and codeine phosphate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some
Carisoprodol + aspirin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some
Aspirin 325 mg and carisoprodol 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some
Product containing aspirin and carisoprodol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some
Measurement of carisoprodol in urine (procedure)	Component	False	Carisoprodol (substance)	Inferred relationship	Some	2
Allergy to carisoprodol	Causative agent (attribute)	True	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol 125 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol 350 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol 350 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol 250 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Aspirin 325 mg and carisoprodol 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some	1
Aspirin 325 mg and carisoprodol 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carisoprodol (substance)	Inferred relationship	Some	3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Carisoprodol (substance)	Inferred relationship	Some	3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Carisoprodol (substance)	Inferred relationship	Some	1
Aspirin- and carisoprodol- and codeine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol 250 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol 350 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol 125 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carisoprodol (substance)	Inferred relationship	Some	1
Product containing aspirin and carisoprodol and codeine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Product containing carisoprodol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Aspirin- and carisoprodol-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Aspirin 325 mg and carisoprodol 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carisoprodol (substance)	Inferred relationship	Some	1
Product containing only aspirin and carisoprodol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Product containing only aspirin and carisoprodol and codeine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Carisoprodol only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Aspirin and carisoprodol and codeine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Product containing only aspirin and carisoprodol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carisoprodol (substance)	Inferred relationship	Some	1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Carisoprodol (substance)	Inferred relationship	Some	2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Carisoprodol (substance)	Inferred relationship	Some	2
Measurement of carisoprodol in urine (procedure)	Component	True	Carisoprodol (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461311011	Carisoprodol (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481243018	Carisoprodol	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491882010	Isopropylmeprobamate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491883017	Carisoprodate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491884011	Isobamate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
797981000172117	carisoprodol	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module